<?xml version="1.0" encoding="UTF-8"?>
<p id="Par32">The assenting diagnosis of COVID-19 is dependent on the viral isolation by polymerase chain reaction (PCR) from sputum, or nasal swab, or throat swab for the categories of those with symptoms or potentially exposed [
 <xref ref-type="bibr" rid="CR58">58</xref>]. The real-time-reverse transcription (RT)-PCR detection of viral nucleic acid test (NAT) is considered as sensitive, specific and able to process large batches of samples [
 <xref ref-type="bibr" rid="CR59">59</xref>]. The RT-PCR results generally become positive after 2–8 days [
 <xref ref-type="bibr" rid="CR60">60</xref>]. However, the commonly used RT-PCR method shows false-negative in some cases, such as mutations of the SARS-CoV-2 genome, variable viral load kinetics or laboratory errors [
 <xref ref-type="bibr" rid="CR61">61</xref>]. It may lack sensitivity, particularly in the advanced phase of infection, and depends closely on the samples’ quality [
 <xref ref-type="bibr" rid="CR62">62</xref>]. As turnaround time of RT-PCR is long, molecular point of care tests (POCT) should be considered in situations where quick results are critical [
 <xref ref-type="bibr" rid="CR59">59</xref>].
</p>
